New Delhi: Medical technology firm Trivitron Healthcare and Investment Funds for Health in Africa (IFHA) today announced launch of a joint venture firm Trivitron Healthcare Africa BV to provide medical devices and instruments in the continent.
The joint venture firm will provide medical devices and instruments with reliable after-sales service support across the continent, thereby improving access and affordability of medical equipment, Trivitron Healthcare said in a statement.
In the first phase, Trivitron Healthcare Africa B V (THA) will be headquartered in Dubai with a direct presence and sales and service infrastructure in four major hubs — Nairobi, Johannesburg, Lagos and Algiers, it added.
“This is a first of its kind venture between the leading medical technology company in India and a leading healthcare private equity investor in Africa, with support from International Finance Corporation,” Trivitron Chairman and MD GSK Velu said.
THA’s initial offering will include a complete range of products and after-sales service support in laboratory medicine, medical imaging, critical care, operating room and renal care, the statement said.
Apart from distributing and supporting products manufactured by Trivitron in its USFDA (US Food and Drug Administration), CE certified factories in India, Finland and Turkey, the JV firm will also distribute and support products from other multinational corporations, it added.
“IFHA has long seen an opportunity to improve access to quality healthcare services by creating a provider of high- quality, affordable medical equipment and services. IFHA is excited to partner with Trivitron and IFC to turn this vision into a reality,” the JV firm’s Managing Partner Max Coppoolse said.